Boundless Bio Inc. Common Stock
NASDAQ: BOLD
$4.15
-$0.09 (-2.1%)
Closing Price on July 5, 2024
BOLD Chart and Intraday Price
BOLD Company Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | TECHNOLOGY |
| Industry | GENERAL |
| Address | NONE |
| Fiscal Year End | December |
| Latest Quarter | 2023-12-31 |
| Market Cap | 301.12M USD |
| Shares Outstanding | 22,239,300 |
BOLD Articles
A renowned billionaire investor, a French energy giant, and other insiders were scooping up shares of these five stocks as the second quarter began.
Published:
Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade Desk and Yext.
Published:
Audentes Therapeutics shares more than doubled on Tuesday after the firm announced that it would be acquired by Astellas. Although Audentes has only been public for just over three years, this...
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku, Tesla, Uber Technologies and...
Published:
Last Updated:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Published: